Cas:53025-53-9 dowex marathon msc (h) ion-exchange resin manufacturer & supplier

We serve Chemical Name:dowex marathon msc (h) ion-exchange resin CAS:53025-53-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

dowex marathon msc (h) ion-exchange resin

Chemical Name:dowex marathon msc (h) ion-exchange resin
CAS.NO:53025-53-9
Synonyms:DOWEX MARATHON MSC (H) ION-EXCHANGE RESIN;dowex macroporous resin;Dowex(R) MSC-1;DOWEX MSC-1, NA(+)-FORM, STRONGLY ACIDIC, 20-50 MESH;MFCD00166450;DOWEXMSC-1 macroporous ion-exchange resin;dowex msc-1 macroporous ion-exchange resin;dowex marathon msc hydrogen form
Molecular Formula:N/A
Molecular Weight:N/A
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:
Exact Mass:
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like DOWEX MARATHON MSC (H) ION-EXCHANGE RESIN chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,dowex marathon msc hydrogen form physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00166450 Use and application,DOWEX MSC-1, NA(+)-FORM, STRONGLY ACIDIC, 20-50 MESH technical grade,usp/ep/jp grade.


Related News: As for the consumer health unit, GSK plans to demerge it by mid-2022, during which GSK will shed at least 80% of its 68% holding in the JV to shareholders. 3β,14-dihydroxy-22-methylene-5β,14β,20S-cardanolide manufacturers Mindset is developing several novel families of next generation psychedelic compounds, as well as an innovative process to chemically synthesize psilocybin as well as its own proprietary compounds. 3-hydroxy-3-methoxymethyl-hexan-2-one-dimethylacetal suppliers The FDA in announcing its approval noted that four, 12-week placebo-controlled clinical studies that included a total of 1,143 participants showed Nourianz offered a statistically significant decrease from baseline in daily “off” time compared to those on placebo. 5-bromo-2-(4-(6-(3-methyl-1,2,4-thiadiazol-5-yl)pyridazin-3-yl)piperazin-1-yl)aniline vendor & factory.